A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters

Published:2017-05-05 Issue:2 Volume:94 Page:239-249
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Keeney Michael¹,Wood Brent L.²³,Hedley Benjamin D.¹,DiGiuseppe Joseph A.⁴^ORCID,Stetler-Stevenson Maryalice⁵,Paietta Elisabeth⁶,Lozanski Gerard⁷,Seegmiller Adam C.⁸,Greig Bruce W.⁸,Shaver Aaron C.⁸,Mukundan Lata⁹,Higley Howard R.⁹,Sigman Caroline C.⁹,Kelloff Gary¹⁰,Jessup J. Milburn¹¹,Borowitz Michael J.¹²

Affiliation:

1. Pathology and Laboratory Medicine; London Health Sciences Centre; London Ontario Canada

2. Seattle Cancer Care Alliance; Seattle Washington

3. University of Washington; Seattle Washington

4. Department of Pathology; Hartford Hospital; Hartford Connecticut

5. National Cancer Institute, National Institutes of Health; Bethesda Maryland

6. Oncology, Montefiore Medical Center; Bronx New York

7. Department of Pathology; Ohio State University; Columbus Ohio

8. Department of Pathology; Microbiology, and Immunology, Vanderbilt University Medical Center; Nashville Tennessee

9. CCS Associates; San Jose California

10. Cancer Imaging Program, National Cancer Institute; Bethesda Maryland

11. Inova Schar Cancer Institute; Falls Church Virginia

12. Department of Pathology; Johns Hopkins Medical Institutions; Baltimore Maryland

Funder

Foundation for the National Institutes of Health

AbbVie

Amgen

Pfizer

Genentech

BD Biosciences and Beckman Coulter, Inc.

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference38 articles.

1. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood;Dongen;Lancet,1998

2. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study;Borowitz;Blood,2008

3. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation;Paiva;Blood,2008

4. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia;Buccisano;Blood,2012

5. Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients;Paiva;Blood,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Faster clinical decisions in B‐cell acute lymphoblastic leukaemia: A single flow cytometric 12‐colour tube improves diagnosis and minimal residual disease follow‐up;British Journal of Haematology;2024-03-03

2. Using Artificial Intelligence to Interpret Clinical Flow Cytometry Datasets for Automated Disease Diagnosis and/or Monitoring;Methods in Molecular Biology;2024

3. A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL;Cancers;2023-11-23

4. Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies;Pediatric Hematology/Oncology and Immunopathology;2023-10-03

5. Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal;Blood Advances;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3